Lupin, an innovation led transnational pharmaceutical company, has announced that it has received final approval from US FDA to market a generic version of Vintage Pharmaceuticals’ Percocet tablets and Braintree Laboratories’s Suprep Bowel Prep Kit. Lupin shall commence promoting both the products shortly.

Lupin’s oxycodone and acetaminophen tablets USP, 2.5 mg/325 mg, 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg is the AA rated generic equivalent of Vintage Pharmaceuticals LLC’s Percocet tablets, 2.5 mg/325 mg, 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg. Oxycodone and acetaminophen tablets USP, 2.5 mg/325 mg, 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg are indicated for relief of moderate to moderately severe pain. Percocet tablets had US sales of USD 838.7 million (IMS MAT December 2016).

Lupin’s sodium sulfate, potassium sulfate, and magnesium sulfate oral solution, 17.5 g/3.13 g/1.6 g per 6 ounces is the AA rated generic equivalent of Braintree Laboratories’ Suprep Bowel Prep Kit. Sodium sulfate, potassium sulfate and magnesium sulfate oral solution, 17.5 g/3.13 g/1.6 g per 6 ounces is indicated for cleansing of the colon in preparation for colonoscopy in adults. Suprep Bowel Prep Kit had US sales of USD 207.2 million (IMS MAT December 2016).

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally. The company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership position in the Anti-TB segment.